top of page

stories

a gap at the heart of molecular science For decades, molecular science has operated with two fundamental data classes. Sequences tell us what a molecule is. Structures show us what a molecule looks like. These two layers have driven enormous progress, from genomics to structural biology, and underpinned much of modern drug discovery and materials design. But there is a third layer that has remained largely elusive: States. How a molecule or material actually behaves under real-world...

Jun 24, 2026

Apoha: unlocking the missing data class of molecular science

a system under pressure Germany has one of the most expensive healthcare systems in the world, and yet patients wait far too long for routine procedures. The structural reason is straightforward: 63% of all surgeries in Germany still happen inpatient, roughly twice the rate of comparable countries like the US, the Netherlands, and Denmark. That means 16.5 million surgeries a year are performed in hospitals where patients stay overnight, at significantly higher cost and with longer waiting...

Jun 24, 2026

Tokura: building the infrastructure for ambulatory surgery in Germany

This month, we announce our investment in Nscale, celebrate Apoha's $36M funding round, share news from Klarna, Mistral, and Dunia, and look back at key events including Deep Tech Momentum, GLOBSEC, and SECA. Read on for these updates and more! portfolio funding apoha announces $36M funding to build liquid state intelligence Apoha has emerged from stealth with a $36M funding round led by Singular, with Draper Associates participating. We've backed Apoha from the very beginning and are proud...

Jun 3, 2026

welcome to our may newsletter

compute is the bottleneck Every major technology shift has its defining constraint. For the AI era, it is compute. Demand for AI infrastructure is growing faster than the industry's ability to deploy it reliably and at scale. The question is no longer whether enterprises, governments, and hyperscalers will need production-grade AI infrastructure; it is who will build it fast enough, and who will run it well. Nscale was founded to answer that question. The UK-headquartered AI infrastructure...

May 19, 2026

Nscale: building the foundational layer for the AI era

the throughput problem in pharma Pharma has no shortage of ideas. It has a shortage of throughput. Roughly 50 new drugs are approved each year despite more than 10,000 known diseases, and R&D spending now exceeds $300 billion annually with costs to bring a single drug to market exceeding $2 billion. Every promising hypothesis still collides with the same constraint: slow, expensive physical experimentation, and more than 90% of clinical candidates ultimately fail. Biological foundation models...

May 18, 2026

Helical: the virtual AI lab powering reproducible drug discovery

redalpine and Sifted recently published the European Dynamism report - a deep dive into six sectors where Europe is accelerating fast and where we believe the next wave of global leaders will emerge. Over the coming weeks, we're going deeper on each one: the thesis, why we believe Europe has a structural advantage, and the top startups to watch. In this edition: Digital health. Digital health is no longer about keeping people healthy. It’s about transforming medical care. The era of step...

Apr 9, 2026

Moving digital health from wellness to clinical reality | redalpine x Sifted European Dynamism report

It was a milestone-packed March: 9fin joined the unicorn club, Basecamp Research launched a trillion gene atlas, we released our European Dynamism report together with Sifted, celebrated 20 years of redalpine at our Family Day, and much more! Read on for these updates and more. portfolio updates 9fin reaches unicorn status in $170M Series C We first invested in 9fin (RAC VI) in their 2021 Series A and have continued to back them in every round since, becoming their largest investor last...

Apr 1, 2026

welcome to our march newsletter

Earlier this month, redalpine and Sifted published the European Dynamism report - a deep dive into six sectors where Europe is accelerating fast and where we believe the next wave of global leaders will emerge. Over the coming weeks, we're going deeper on each one: the thesis, why we believe Europe has a structural advantage, and the top startups and scale-ups to watch. First up: intelligent enterprise. AI is already rewriting the rules of office work. Models draft emails, write code, field...

Mar 30, 2026

The real moat in the age of AI | redalpine x Sifted European Dynamism report

When redalpine was founded twenty years ago, professional venture capital barely existed in Europe. Unicorns weren't a thing. Too many of the continent's best founders followed the capital to California. And yet the ingredients were always here. The scientific talent, the precision engineering culture, the deep university research base: none of that was ever the problem. What was missing was the capital to unlock it. The same cannot be said for today. In 2026, roughly one new unicorn emerges...

Mar 5, 2026

european dynamism: six sectors where europe can lead

Dear Reader, As Europe’s innovation landscape accelerates, the Summit Fund continues to back companies shaping the continent’s technological and industrial future. From Klarna’s expansion into next-generation digital payments to Proxima Fusion’s landmark agreement to develop Europe’s first grid-connected fusion power plant, our portfolio reflects Europe’s growing ambition across software, AI, and deep tech. At the same time, through our early-stage strategy and RAC VII, we’re investing at the...

Mar 4, 2026

reaching the summit

From Proxima Fusion’s €2bn agreement to build Europe’s first commercial fusion plant, to Sanity Group's successful exit, plus news from Albatross, Hilo, Memo Therapeutics, and Mistral AI, along with plenty of events - it’s been a packed February for us and our portfolio companies! Read on for these updates and more. portfolio updates Proxima Fusion’s €2B agreement to build Europe's first commercial fusion power plant Proxima Fusion (RAC VII) has signed a landmark Memorandum of Understanding...

Mar 2, 2026

welcome to our february newsletter

Did January sprint past, or was that just us?! Regardless whether you're just back from vacation or already deep in work mode, we hope your 2026 is off to a strong start. At redalpine, the year has quickly kicked into high gear, featuring plenty of momentum across our portfolio, events including our ski day and office warming, and much more. Read on for all of our updates.. portfolio updates Basecamp Research (RAC VII) unveiled EDEN-AI, a new family of foundation models designed to...

Feb 2, 2026

welcome to our january newsletter

bottom of page